Expression of Prostate-Specific Membrane Antigen (PSMA) on Biopsies Is an Independent Risk Stratifier of Prostate Cancer Patients at Time of Initial Diagnosis

Background: Stratifying prostate cancer (PCa) patients into risk groups at time of initial diagnosis enabling a risk-adapted disease management is still a major clinical challenge. Existing studies evaluating the prognostic potential of PSMA (prostate-specific membrane antigen) for PCa were performe...

Descripción completa

Detalles Bibliográficos
Autores principales: Hupe, Marie Christine, Philippi, Christian, Roth, Doris, Kümpers, Christiane, Ribbat-Idel, Julika, Becker, Finn, Joerg, Vincent, Duensing, Stefan, Lubczyk, Verena Helena, Kirfel, Jutta, Sailer, Verena, Kuefer, Rainer, Merseburger, Axel Stuart, Perner, Sven, Offermann, Anne
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Frontiers Media S.A. 2018
Materias:
Oncology
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6307416/
https://www.ncbi.nlm.nih.gov/pubmed/30619757
http://dx.doi.org/10.3389/fonc.2018.00623

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6307416/
https://www.ncbi.nlm.nih.gov/pubmed/30619757
http://dx.doi.org/10.3389/fonc.2018.00623

Ejemplares similares